ClinicalTrials.gov
public full text
Public Domain
Optimal Treatment for Recurrent Clostridium Difficile
The purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the treatment of recurrent Clostridium difficile infection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection#1031459
- Assessment of vancomycin utilization among Lebanese hospitals#242005
- A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)#884876
- Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection#876270
- Oral Vancomycin for Preventing Clostridium Difficile Recurrence#268054
Record · ID 881457
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive